SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-042088
Filing Date
2016-11-14
Accepted
2016-11-14 16:46:55
Documents
69
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rpbif20160901_10q.htm 10-Q 1241200
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11048
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 11027
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6232
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6211
  Complete submission text file 0001437749-16-042088.txt   5629865

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS rpbif-20160930.xml EX-101.INS 1058238
7 EXHIBIT 101.SCH rpbif-20160930.xsd EX-101.SCH 60720
8 EXHIBIT 101.CAL rpbif-20160930_cal.xml EX-101.CAL 40446
9 EXHIBIT 101.DEF rpbif-20160930_def.xml EX-101.DEF 421726
10 EXHIBIT 101.LAB rpbif-20160930_lab.xml EX-101.LAB 340925
11 EXHIBIT 101.PRE rpbif-20160930_pre.xml EX-101.PRE 438486
Mailing Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2
Business Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2 604-456-6010
RESPONSE BIOMEDICAL CORP (Filer) CIK: 0000806888 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50571 | Film No.: 161995606
SIC: 8734 Services-Testing Laboratories